oncology

Lupride Depot 3.75 mg Injection contains Leuprolide Acetate 3.75 mg, a long-acting GnRH (gonadotropin-releasing hormone) agonist. It works by regulating the release of reproductive hormones and, with continued treatment, suppressing the production of sex hormones. Leuprolide is used in the management of hormone-dependent conditions, including certain prostate cancer treatment protocols. It may also be prescribed for other conditions requiring suppression of ovarian or reproductive hormone activity, depending on the physician's treatment plan. Product Information Brand: Lupride Depot 3.75 mg Injection Active Ingredient: Leuprolide Acetate Strength: 3.75 mg Drug Class: GnRH Agonist Category: Oncology / Hormonal Therapy Dosage Form: Depot Injection Prescription: Prescription medicine Important: Lupride Depot should be administered by or under the supervision of a qualified healthcare professional.

Lupride 1 mg Injection contains Leuprolide Acetate, a synthetic GnRH (gonadotropin-releasing hormone) agonist. It works by regulating the release of reproductive hormones and, with continued treatment, can significantly suppress sex-hormone production. Leuprolide is used in the management of hormone-dependent conditions, including certain prostate cancer treatment protocols and other conditions where hormonal suppression is medically indicated. Product Information Brand: Lupride 1 mg Injection Active Ingredient: Leuprolide Acetate Strength: 1 mg Drug Class: GnRH Agonist Category: Oncology / Hormonal Therapy Dosage Form: Injection Prescription: Prescription medicine Important: Lupride should be administered only according to a healthcare professional’s prescription and treatment plan.

Lupride Depot 22.5 mg Injection contains Leuprolide Acetate 22.5 mg, a long-acting GnRH (gonadotropin-releasing hormone) agonist used as hormonal therapy. Product Description Lupride Depot 22.5 mg Injection is a depot formulation designed to provide sustained suppression of sex-hormone production. It is primarily used in the hormonal treatment of advanced prostate cancer, where reducing testosterone levels can help slow the growth of hormone-sensitive cancer cells. The medicine is administered by a healthcare professional according to the prescribed treatment schedule. As a prescription hormonal medicine, it should be used only under appropriate medical supervision. Key Information Brand: Lupride Depot 22.5 mg Injection Active Ingredient: Leuprolide Acetate 22.5 mg Drug Class: GnRH Agonist Category: Oncology / Hormonal Therapy Therapeutic Area: Prostate Cancer Dosage Form: Depot Injection Route: Injection Prescription: Prescription medicine Uses Lupride Depot may be prescribed for: Hormone-sensitive/advanced prostate cancer Androgen-deprivation therapy as determined by a physician Important Safety Information Possible effects include hot flashes, sweating, fatigue, injection-site reactions, changes in mood, decreased libido, and changes in bone density. Testosterone may initially rise temporarily after treatment begins, which can cause a temporary worsening of symptoms in some patients.

Lupride Depot 45 mg Injection contains Leuprolide Acetate 45 mg, a gonadotropin-releasing hormone (GnRH) agonist manufactured by Sun Pharmaceutical Industries Ltd. It is a long-acting hormonal therapy used primarily in the management of hormone-dependent conditions, particularly advanced prostate cancer. Leuprolide works by initially stimulating and then suppressing the pituitary gland's release of reproductive hormones, resulting in a significant reduction in testosterone levels in men. This hormone suppression helps slow the growth of hormone-sensitive prostate cancer cells. The 45 mg depot formulation is designed for extended-duration treatment; comparable leuprolide 45 mg depot formulations are administered at approximately 6-month intervals under medical supervision.

Zucarfil (Carfilzomib Injection 60 mg) – Product Description Zucarfil contains Carfilzomib 60 mg, a targeted anti-cancer medicine used for the treatment of relapsed or refractory multiple myeloma (RRMM). It belongs to the proteasome inhibitor class of medicines and works by irreversibly blocking the 20S proteasome, causing the accumulation of damaged proteins within cancer cells. This leads to cellular stress and programmed cancer cell death (apoptosis), helping slow disease progression. Zucarfil is supplied as a lyophilized powder for intravenous (IV) infusion and is administered by qualified healthcare professionals. It is commonly used in combination with medicines such as dexamethasone, lenalidomide, or daratumumab, depending on the patient's treatment regimen and clinical condition. Active Ingredient Carfilzomib 60 mg Dosage Form Lyophilized Powder for Injection (IV Infusion) Therapeutic Indications Relapsed Multiple Myeloma Refractory Multiple Myeloma Multiple Myeloma Combination Therapy Other approved indications as determined by the treating oncologist How It Works Carfilzomib selectively and irreversibly inhibits the 20S proteasome, preventing the breakdown of unwanted proteins inside cancer cells. The resulting protein buildup disrupts normal cell function, triggering apoptosis and reducing the growth of multiple myeloma cells. Key Features Targeted proteasome inhibitor for multiple myeloma Effective in relapsed and refractory disease Administered by intravenous infusion under specialist supervision Commonly used in combination with established myeloma therapies Manufactured according to stringent pharmaceutical quality standards Storage Store refrigerated at 2°C–8°C. Protect from light and do not freeze. Keep out of reach of children. Note: Zucarfil (Carfilzomib Injection 60 mg) is a prescription-only medicine and should be administered only by qualified healthcare professionals experienced in oncology. Patients should be monitored regularly for blood counts, kidney function, liver function, cardiac status, and infusion-related reactions throughout treatment.

Zucarb (Carboplatin Injection) – Product Description Zucarb contains Carboplatin, a prescription platinum-based chemotherapy medicine used in the treatment of various solid tumors, including ovarian cancer, lung cancer, head and neck cancer, and other malignancies. It belongs to the platinum-containing antineoplastic agents and works by damaging the DNA of cancer cells, preventing their growth and division, ultimately leading to cancer cell death. Zucarb is administered as an intravenous (IV) infusion by qualified healthcare professionals. It may be used alone or in combination with other chemotherapy medicines depending on the type and stage of cancer, as well as the patient's overall treatment plan. Active Ingredient Carboplatin Dosage Form Sterile Injection for Intravenous (IV) Infusion Therapeutic Indications Ovarian Cancer Non-Small Cell Lung Cancer (NSCLC) Small Cell Lung Cancer (SCLC) Head and Neck Cancer Endometrial Cancer Other solid tumors as recommended by the treating oncologist How It Works Carboplatin forms DNA cross-links within cancer cells, preventing DNA replication and repair. This disrupts cell division and triggers the death of rapidly dividing cancer cells, helping to slow or stop tumor growth. Key Features Platinum-based chemotherapy with proven clinical efficacy Effective against a wide range of solid tumors Suitable for use as monotherapy or combination chemotherapy Administered under specialist oncology supervision Manufactured according to stringent pharmaceutical quality standards Storage Store according to the manufacturer's recommendations. Protect from excessive heat, freezing, and direct light. Keep out of reach of children. Note: Zucarb (Carboplatin Injection) is a prescription-only chemotherapy medicine and should only be administered by qualified healthcare professionals experienced in oncology. Regular monitoring of blood counts, kidney function, liver function, andelectrolyte levels is recommended throughout treatment.

Zovorin Injection (Leucovorin Calcium Injection 50 mg) – Product Description Zovorin Injection contains Leucovorin Calcium 50 mg, a folinic acid (reduced folic acid) medicine widely used in oncology and supportive cancer care. It is primarily administered to reduce the toxic effects of high-dose methotrexate therapy (leucovorin rescue) and to enhance the effectiveness of 5-Fluorouracil (5-FU) in the treatment of colorectal cancer. Leucovorin is also indicated for the treatment of certain folate deficiency conditions when oral therapy is not suitable. It is administered by qualified healthcare professionals through intravenous (IV) or intramuscular (IM) injection according to the prescribed treatment protocol. Active Ingredient Leucovorin Calcium 50 mg Dosage Form Sterile Injection Therapeutic Indications High-Dose Methotrexate Rescue Therapy Colorectal Cancer (in combination with 5-Fluorouracil) Folate Deficiency requiring injectable treatment Other approved indications as determined by the treating physician How It Works Leucovorin is an active form of folic acid that helps protect normal cells from the toxic effects of methotrexate without reducing its anti-cancer activity. When used with 5-Fluorouracil (5-FU), it enhances the binding of 5-FU to its target enzyme, improving the chemotherapy's effectiveness against cancer cells. Key Features Provides effective rescue following high-dose methotrexate therapy Enhances the efficacy of 5-Fluorouracil in colorectal cancer treatment Supports healthy folate metabolism Suitable for intravenous or intramuscular administration Manufactured according to stringent pharmaceutical quality standards Storage Store according to the manufacturer's recommendations. Protect from light and excessive heat. Keep out of reach of children. Note: Zovorin Injection (Leucovorin Calcium 50 mg) is a prescription-only medicine and should be administered only under the supervision of qualified healthcare professionals. Treatment should follow established oncology protocols with appropriate clinical monitoring.